Uterine Cancer
Uterine cancer is a condition strongly linked to exposure to unopposed oestrogen. Factors such as early onset of menses, late menopause, obesity, PCOS, use of birth control pills, hypertension, and diabetes are associated with increased risk, while progesterone is considered protective. Genetic mutations may include PTEN loss with activation of the P13K/Akt/mTOR pathway. Common symptoms include spotting between menses, any post-menopausal vaginal bleeding, colicky abdominal pains, backache, leg oedema, unexplained weight loss, and in some cases, a cough with bloody phlegm. Screening typically involves a pelvic exam, which may be followed by abdominal or transvaginal CT or PET scans; the primary tumour marker used is CA-125. Herbal and supplement support is intended to be complementary and should be coordinated with the medical team. Safety and interaction cautions are paramount: it is essential to avoid Ashwagandha (due to DHEA content), Maca, and sterols/sterolins. Grapefruit must be strictly avoided as it may interact with various pathways. Reducing alcohol intake is advised, and if alcohol is consumed, folate and green tea may be used to limit risk. The goal of this supportive approach is to address factors such as the Akt/P13K/mTOR pathway, inflammation, aromatase inhibition, angiogenesis, and apoptosis. Vulvar cancer, a related concern, is associated with HPV virus and smoking; surgery is often the primary intervention.
The full protocol is for members
Unlock the herbs, supplements, dietary guidance, lifestyle plan and recommended products for Uterine Cancer.
Your assessment and results stay saved — upgrading only unlocks more of them.
See membership plans